NTLA
Intellia Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$12.76
-0.09 ▼ -0.70%
🌙 3월 13일 7:46 PM ET (한국 3/14 08:46)
$12.85
+0.09 ▲ +0.71%
| Index | RUT | P/E | - | EPS (ttm) | -3.83 | Insider Own | 5.12% | Shs Outstand | 0.12B | Perf Week | -5.06% |
| Market Cap | 1.51B | Forward P/E | - | EPS next Y | 44.73% | Insider Trans | -0.42% | Shs Float | 0.11B | Perf Month | 6.33% |
| Enterprise Value | 1.15B | PEG | - | EPS next Q | -0.91 | Inst Own | 85.24% | Short Float | 39.53% | Perf Quarter | 36.18% |
| Income | -0.41B | P/S | 22.28 | EPS this Y | 5.02% | Inst Trans | 1.53% | Short Ratio | 9.21 | Perf Half Y | 11.73% |
| Sales | 0.07B | P/B | 2.21 | EPS next 5Y | 43.47% | ROA | -40.6% | Short Interest | 44.31M | Perf YTD | 41.94% |
| Book/sh | 5.77 | P/C | 3.35 | EPS past 3/5Y | 14.82% -9.7% | ROE | -53.48% | 52W High | -54.83% ($28.25) | Perf Year | 38.39% |
| Cash/sh | 3.81 | P/FCF | - | Sales past 3/5Y | 9.09% 3.13% | ROIC | -55.9% | 52W Low | 116.27% ($5.90) | Perf 3Y | -66.69% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 27.11% | Gross Margin | 76.43% | Volatility(W/M) | 5.79% 7.26% | Perf 5Y | -80.53% |
| Dividend TTM | - | EV/Sales | 17.01 | Sales Y/Y TTM | 16.92% | Oper. Margin | -642.06% | ATR (14) | 0.98 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.08 | EPS Q/Q | 34.71% | Profit Margin | -609.85% | RSI (14) | 47.59 | Recom | 2.12 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.08 | Sales Q/Q | 78.79% | SMA20 | -4.03% ($13.3) | Beta | 2.02 | Target Price | $25.2 |
| Payout | - | Debt/Eq | 0.14 | Earnings | 2000000 | SMA50 | 1.16% ($12.61) | Rel Volume | 0.59 | Prev Close | $12.85 |
| Employees | 377 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | 13.08% 92.1% | SMA200 | 2.52% ($12.45) | Avg Volume(3M) | 4.81M | Price | $12.76 |
| IPO | 2016/5/6 | Option/Short | Yes/Yes | Trades | 22189 | Volume | 2,853,878 | Change | -0.7% |
뉴스 로딩 중...